Answers are grounded in this paper and cite their sources.
Propensity-matched cohort study reveals improved survival with beta-blockers in high-risk post-myocardial infarction patients with COPD, suggesting safe cardiovascular benefit.
In the specific setting of a well-treated cohort of high-risk MI survivors, beta-blockers were associated with better outcomes in patients with COPD.
No takes yet. Share an insight, caveat, or question.
Coiro et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: